Yingqun Zhou Selected Research

Concanavalin A

7/2018	Isorhamnetin: A hepatoprotective flavonoid inhibits apoptosis and autophagy via P38/PPAR-α pathway in mice.
1/2018	The Protective Effects of Levo-Tetrahydropalmatine on ConA-Induced Liver Injury Are via TRAF6/JNK Signaling.
5/2016	15d-PGJ2 alleviates ConA-induced acute liver injury in mice by up-regulating HO-1 and reducing hepatic cell autophagy.
1/2016	Epigallocatechin-3-gallate attenuates apoptosis and autophagy in concanavalin A-induced hepatitis by inhibiting BNIP3.
1/2015	Protective effects of astaxanthin on ConA-induced autoimmune hepatitis by the JNK/p-JNK pathway-mediated inhibition of autophagy and apoptosis.
1/2015	Protective effects of N-acetylcysteine in concanavalin A-induced hepatitis in mice.
1/2014	Hydrogen sulfide, a potential novel drug, attenuates concanavalin A-induced hepatitis.
1/2014	15-Deoxy- γ 12,14-prostaglandin J2 Reduces Liver Impairment in a Model of ConA-Induced Acute Hepatic Inflammation by Activation of PPAR γ and Reduction in NF- κ B Activity.
1/2013	Protective effects of necrostatin-1 against concanavalin A-induced acute hepatic injury in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yingqun Zhou Research Topics

Disease

12	Hepatocellular Carcinoma (Hepatoma) 12/2017 - 01/2014
10	Neoplasms (Cancer) 12/2020 - 01/2014
8	Hepatitis 01/2018 - 01/2013
7	Inflammation (Inflammations) 11/2019 - 01/2014
7	Fibrosis (Cirrhosis) 11/2019 - 01/2017
6	Liver Cirrhosis (Hepatic Cirrhosis) 11/2019 - 01/2014
6	Autoimmune Hepatitis 01/2018 - 01/2013
6	Ischemia 01/2018 - 01/2014
5	Reperfusion Injury 01/2018 - 01/2014
5	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2015 - 01/2013
4	Liver Neoplasms (Liver Cancer) 08/2021 - 05/2014
3	Pruritus (Itching) 01/2015 - 01/2015
2	Carcinogenesis 12/2020 - 11/2019
2	Massive Hepatic Necrosis 07/2018 - 05/2016
2	Necrosis 07/2017 - 01/2013
2	Wounds and Injuries (Trauma) 01/2017 - 01/2017
2	Non-alcoholic Fatty Liver Disease 01/2017 - 01/2016
2	Neoplasm Metastasis (Metastasis) 07/2015 - 04/2015
2	Pancreatic Neoplasms (Pancreatic Cancer) 07/2015 - 01/2014
2	Disease Progression 05/2015 - 11/2014
1	Pneumocystis Infections 06/2021
1	Pulmonary Aspergillosis 06/2021
1	Chronic Hepatitis (Chronic Active Hepatitis) 11/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018
1	Ulcerative Colitis 01/2018
1	Colitis 01/2018
1	Weight Loss (Weight Reduction) 12/2017
1	Ascites 11/2017
1	Portal Hypertension 05/2017

Drug/Important Bio-Agent (IBA)

9	Concanavalin AIBA 07/2018 - 01/2013
5	CytokinesIBA 01/2018 - 01/2013
4	Alanine Transaminase (SGPT)IBA 01/2016 - 01/2015
4	astaxanthine (astaxanthin)IBA 09/2015 - 01/2014
4	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2015 - 01/2013
3	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2019 - 01/2016
3	Biological ProductsIBA 07/2018 - 01/2015
3	AntioxidantsIBA 07/2018 - 01/2015
3	15-deoxyprostaglandin J2IBA 05/2016 - 01/2014
3	Proteins (Proteins, Gene)FDA Link 05/2015 - 01/2013
3	Pharmaceutical PreparationsIBA 01/2015 - 01/2014
2	shikoninIBA 01/2019 - 01/2017
2	3-methylquercetinIBA 01/2019 - 07/2018
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2018 - 01/2014
2	GenisteinIBA 11/2017 - 04/2015
2	fucoidanIBA 10/2017 - 01/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2017 - 01/2015
2	LipidsIBA 01/2017 - 01/2016
2	EnzymesIBA 01/2017 - 01/2016
2	QuercetinIBA 01/2017 - 01/2017
2	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2016 - 01/2016
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2016 - 05/2015
2	ResveratrolIBA 05/2015 - 01/2015
2	Biomarkers (Surrogate Marker)IBA 04/2015 - 01/2014
2	BezafibrateIBA 01/2015 - 01/2015
2	Acetylcysteine (Siran)FDA LinkGeneric 01/2015 - 01/2014
2	Interleukin-6 (Interleukin 6)IBA 01/2015 - 01/2014
2	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2014 - 01/2014
1	Voriconazole (Vfend)FDA LinkGeneric 06/2021
1	Caspofungin (Cancidas)FDA Link 06/2021
1	Sulfamethoxazole FDA LinkGeneric 06/2021
1	Thymidine Monophosphate (TMP)IBA 06/2021
1	Trimethoprim (Proloprim)FDA LinkGeneric 06/2021
1	MicroRNAs (MicroRNA)IBA 12/2020
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 12/2020
1	Bile Acids and Salts (Bile Acids)IBA 11/2019
1	Glycochenodeoxycholic Acid (Glycochenodeoxycholate)IBA 11/2019
1	Glycocholic AcidIBA 11/2019
1	ursodoxicoltaurineIBA 11/2019
1	AcidsIBA 11/2019
1	Taurocholic Acid (Sodium Taurocholate)IBA 11/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019
1	p38 Mitogen-Activated Protein KinasesIBA 01/2019
1	FlavonoidsIBA 07/2018
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 01/2018
1	Dextran SulfateIBA 01/2018
1	Mesalamine (Mesalazine)FDA LinkGeneric 01/2018
1	beraprostIBA 01/2018
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2017
1	Sorafenib (BAY 43-9006)FDA Link 12/2017
1	Hypoxia-Inducible Factor 1IBA 11/2017
1	Indicators and Reagents (Reagents)IBA 11/2017
1	Urea (Carbamide)FDA LinkGeneric 11/2017
1	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 11/2017
1	CreatinineIBA 11/2017
1	NitrogenIBA 11/2017
1	Long Noncoding RNAIBA 09/2017
1	Competitive Endogenous RNAIBA 09/2017
1	methyl jasmonateIBA 07/2017
1	Adenosine Triphosphate (ATP)IBA 07/2017
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2017
1	ReninIBA 05/2017
1	Angiotensin Receptor AntagonistsIBA 05/2017
1	AngiotensinsIBA 05/2017

Therapy/Procedure

18	Therapeutics 01/2018 - 01/2013
4	Ligation 01/2019 - 01/2016
3	Intraperitoneal Injections 01/2019 - 01/2014
2	Liver Transplantation 01/2017 - 05/2015
2	Transplantation 01/2017 - 01/2014
1	Immunotherapy 08/2021
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2018